Table 1 Patients’ characteristics at baseline
Characteristic | Total (N = 376) Median (25%,75%) or mea ± SD | ||
|---|---|---|---|
Age | 60 (53, 65) | ||
Sex | Female | 158 (42%) | |
Male | 218 (58%) | ||
BMI | 23.86 ± 3.2 | ||
Address | Country | 155 (41.2%) | |
Town | 221 (58.8%) | ||
Smoking status | Former | 164 (43.6%) | |
Never | 43.6 (56.4%) | ||
Tumor site | RUL | 81 (21.5%) | |
LUL | 103 (27.4%) | ||
RLL | 82 (21.8%) | ||
LLL | 83 (22.1%) | ||
RML | 27 (7.2%) | ||
Histologic subtype | Adeno | 233 (62%) | |
Squamous | 90 (23.9%) | ||
SCLC | 25 (6.6%) | ||
Another | 28 (7.4%) | ||
Differentiation | Well | 66 (17.6%) | |
Moderately | 90 (23.9%) | ||
Poorly | 220 (58.5%) | ||
PIS | Yes | 94 (25%) | |
No | 282 (75%) | ||
TNM staging | I | 205 (54.5%) | |
II | 171 (45.5%) | ||
ECOG PS | 0–1 | 320 (85.1%) | |
2–4 | 56 (14.9%) | ||
Basic illness | Hypertension | 59 (15.7%) | |
Diabetes | 20 (5.3%) | ||
Tumor size | 32.68 ± 16.62 | ||
Lung function | FEV1 | 2.37 ± 0.63 | |
FEV1% | 78.65 ± 9.84 | ||
DLCO | 6.74 ± 1.91 | ||